Windward Bio

Transforming treatment for people living with serious immunological conditions

Basel, United States · Founded 2025 · $365.0M raised

Headquarters
Basel
Employees
1–10
Founded
2025
Business Model
B2B
Total Funding
$365.0M
Last Round
$165.0M Growth EquityMay 2026
Rounds
2

About

Windward Bio is a clinical-stage biotechnology company committed to transforming treatment for people living with serious immunological conditions. Its lead program is WIN378, a potential best-in-disease, ultra long-acting anti-TSLP monoclonal antibody in Phase 2/3 trials for asthma and Phase 2 for COPD. The company is headquartered in Basel, Switzerland and was founded in 2025.

Summary

Windward Bio is a Biotech company based in Basel, United States, founded in 2025. It has raised $365.0M in total across 2 rounds, most recently a $165.0M Growth Equity round in May 2026. Investors include OrbiMed, Blue Owl Capital and Novo Holdings A/S.

Tech & App Stack

3 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Sign up to view the funding chart

Create a free account with 25 free credits every month, no card needed, to unlock funding history, valuations, and tech stacks.

Growth EquityGrowth RoundMay 2026
$165.0M

Sign up to see all 2 rounds

Series A through Growth Equity — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Windward Bio on Indexed.vc
<a href="https://indexed.vc/companies/windward-bio"><img src="https://indexed.vc/api/badge/company/windward-bio" alt="Windward Bio on Indexed.vc" width="260" height="76" /></a>